Jeremy Berke

Hi! I'm the founder and EIC of Cultivated, a newsletter bringing you everything you need to know about the cannabis industry. I formerly launched and led cannabis industry coverage at Business Insider. Beyond writing, I'm an MBA student at Columbia Business School.

👎 Another WSJ editorial on cannabis misses the mark

Apr 28, 2026

•

4 min read

👎 Another WSJ editorial on cannabis misses the mark

Plus, DEA moves forward with dispensaries

Jeremy Berke

👎 Another WSJ editorial on cannabis misses the mark

Rescheduling is official. But we’ve got more questions than answers.

Rescheduling is back on the menu. Maybe?

📈 High cannabis taxes can push consumers back to the illicit market

👎 The NYT’s editorial on cannabis is bad policy journalism

Indiana Dem pushes for decriminalization ✅

New York cannabis sales hit $2.5 billion 📈

Trump signs Executive Order to reclassify cannabis 📈📈

Cannabis stocks go haywire 📈

Gov. Hochul fires acting OCM director, drops Omnium investigation 🗽

California cannabis sales keep falling 📉

Senator Paul’s move to strike hemp ban fails 🥊

Lawmakers strike deal to ban intoxicating hemp 🛑

NY’s cannabis industry is booming, but anger remains 🗽

Trump post sends cannabis stocks into a Monday frenzy 📈

Minnesota cannabis sales kick off 🚀

Glass House Brands slashes guidance after ICE raids

Trump teases rescheduling decision in the next ‘few weeks’ 👀

NY lawmaker proposes legislation to ‘grandfather’ dispensary locations 🗽

Attorneys tell NY dispensaries to start defending their locations 👀

DEA has a new permanent head. What’s next for rescheduling? 👀

Why the WSJ piece ‘Legal Marijuana’s Disastrous Legacy’ missed the mark

Pro-Trump influencers push federal cannabis reform 👀

Aurora Cannabis bats away two fake news stories 👀

Federal Republicans push back on cannabis rescheduling 🥊

Cultivated